Your browser doesn't support javascript.
loading
Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52.
Smolen, Josef S; Mease, Philip; Tahir, Hasan; Schulze-Koops, Hendrik; de la Torre, Inmaculada; Li, Lingnan; Hojnik, Maja; Sapin, Christophe; Okada, Masato; Caporali, Roberto; Gratacós, Jordi; Goupille, Philippe; Liu Leage, Soyi; Pillai, Sreekumar; Nash, Peter.
Afiliación
  • Smolen JS; Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria josef.smolen@meduniwien.ac.at.
  • Mease P; Providence St Joseph Health, Rentton, Washington, USA.
  • Tahir H; Swedish Medical Center, Seattle, Washington, USA.
  • Schulze-Koops H; Royal Free London NHS Foundation Trust, London, UK.
  • de la Torre I; Division of Rheumatology and Clinical Immunology, Department of Internal Medicine IV, Ludwig Maximilians University Munich, Munich, Germany.
  • Li L; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Hojnik M; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Sapin C; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Okada M; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Caporali R; Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan.
  • Gratacós J; Department of Clinical Sciences and Community Health, University of Milan, G. Pini Hospital, Milan, Lombardia, Italy.
  • Goupille P; Rheumatology Department, Hospital Universitario Parc Taulí, Barcelona, Spain.
  • Liu Leage S; Department of Rheumatology, Regional University Hospital Centre Tours, Tours, Centre, France.
  • Pillai S; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Nash P; Eli Lilly and Company, Indianapolis, Indiana, USA.
Ann Rheum Dis ; 79(10): 1310-1319, 2020 10.
Article en En | MEDLINE | ID: mdl-32660977
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Psoriásica / Antirreumáticos / Anticuerpos Monoclonales Humanizados / Adalimumab Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Artritis Psoriásica / Antirreumáticos / Anticuerpos Monoclonales Humanizados / Adalimumab Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article